Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV

Background & Aims: Bulevirtide (BLV) is a small lipopeptide agent that specifically binds to the sodium taurocholate cotransporting polypeptide (NTCP) bile salt transporter and HBV/HDV receptor on the surface of human hepatocytes and inhibits HDV and HBV entry. As a satellite virus of HBV, HDV v...

詳細記述

書誌詳細

主要な著者:	Roberto Mateo, Simin Xu, Alex Shornikov, Tahmineh Yazdi, Yang Liu, Lindsey May, Bin Han, Dong Han, Ross Martin, Savrina Manhas, Christopher Richards, Caleb Marceau, Thomas Aeschbacher, Silvia Chang, Dmitry Manuilov, Julius Hollnberger, Stephan Urban, Tarik Asselah, Dzhamal Abdurakhmanov, Pietro Lampertico, Evguenia Maiorova, Hongmei Mo
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2023-11-01
シリーズ:	JHEP Reports
主題:	hepatitis delta virus hepatitis Bulevirtide
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2589555923002240
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!